Latest filing published 12 Sept 2024 for UroGen Pharma Ltd..
Insider track record
No signal scores available.
Dong Kim: trading record in brief
This profile gathers the share dealings of Dong Kim in UroGen Pharma Ltd. Over a trading history stretching from 31 January 2024 to 9 September 2024, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 12 September 2024, reports an option exercise in UroGen Pharma Ltd. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dong Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 sharesOrdinary SharesSEC:0001437749-24-029036:0
- 3,333 sharesOrdinary SharesSEC:0001437749-24-003794:0
- 3,333 sharesOrdinary SharesSEC:0001437749-24-003014:0
3 of 3 declarations
